revenue $1.62B, net income $62.2M. SelectQuote FY2026: net income to common swings to loss on below-the-line costs

Filed August 25, 2026 · Period ending June 30, 2026 · Compared to 10-K Aug 21, 2025 · ~2 min read

Key Changes

• high

  Net income to common swung to -$11.6M (diluted EPS -$0.06) from $2.4M prior year despite operating income rising 8% to $73.9M, driven by $9.2M net below-the-line drag (non-operating/other +$22.4M offset by income tax -$13.2M).

  MD&A: Operating Results verify on EDGAR →
• high

  NYSE notified the company on March 19, 2026 of non-compliance with minimum share price requirement (below $1.00 for 30 consecutive days); company plans reverse stock split to cure deficiency or faces delisting.

  Risk Factors verify on EDGAR →
• high

  Revenue grew 6.0% to $1.62B, decelerating from 16% prior year, as pharmacy revenue growth slowed to 14% (from 57%) and Senior submitted policies fell 6% on 13% lower close rates.

  MD&A: Revenue verify on EDGAR →